Metro South Health is committed to and recognised as improving health outcomes and preventing disease through translational research. Our clinical and laboratory research endeavours have benefitted generations of families around the world.
Metro South Health is committed to ensuring all research conducted within its facilities, or in collaboration with external entities, is of the highest ethical and scientific standard and undertaken in a manner that provides optimal outcomes for patients, our community, our researchers and our organisation.
Our major research precinct is the Princess Alexandra Hospital, which hosts Australia’s most advanced medical research facilities, the Translational Research Institute (TRI) and the Clinical Research Facility (CRF). Metro South Health also supports research: at the Logan, Redland and QEII hospitals; in Addiction Drug and Mental Health Services; and through the provision of research biobanking services.
We have strong links with a range of leading universities and institutes both locally and nationally and are a foundation partner of Queensland’s first NHMRC designated Academic Health and Translational Research Centre, Brisbane Diamantina Health Partners (BDHP).
The Metro South Research has been charged with this responsibility and is the coordinating body for research compliance, support and development across Metro South Health. It is located in the Translational Research Institute. Contact us if you would like more information.